MENU
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioMarin Pharmaceutical (BMRN) Earnings Date & Reports
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BMRN is expected to report earnings to rise 13.33% to $1.36 per share on November 03
Q3'26
Est.
$1.36
Q2'26
Beat
by $0.25
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.31
Q3'25
Beat
by $0.20
The last earnings report on August 06 showed earnings per share of $1.20, beating the estimate of 94 cents. With 417.14K shares outstanding, the current market capitalization sits at 12.70B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of innovative pharmaceuticals for serious diseases & medical conditions
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3221
Web
https://www.biomarin.com